This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Bariatric surgery is more effective in controlling hypertension rates, or high bloodpressure, in people with obesity and uncontrolled high bloodpressure compared to bloodpressure medication alone, according to a new study.
ObjectivesThis study aimed to investigate the association between the weight-adjusted waist index (WWI) and the prevalence of hypertension in U.S. The definition of hypertension was based on self-reported history of hypertension, antihypertensive drug use, and bloodpressure measurements. 2.61; P < 0.0001).
The associations between obesity and hypertension are widely known, but a new JACC study reveals that weight-reducing gastric bypass surgery has a significant and lasting impact on patients’ need for antihypertensives. vs. 2.4%) All gastric bypass patients eliminated their resistant hypertension (from 15.2%
Objectives In postmenopausal states, women may not maintain bloodpressure (BP) in the same way as men, even though most women follow their treatment plans and prescriptions more consistently than men. Biological and lifestyle factors influence the progression of hypertension in postmenopausal women (PMW).
a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S. We believe suppression of aldosterone production by lorundrostat has the potential to reduce the nocturnal hypertension driving adverse cardiovascular outcomes.
Additionally, 94 cases of tumor-associated hypertension and 96 cases of primary hypertension were randomly selected for comparison. Additionally, 94 cases of tumor-associated hypertension and 96 cases of primary hypertension were randomly selected for comparison. 13.21) vs. (80.41±10.71) 13.19) vs. (80.69±10.98)
Background Worldwide obesity has a high prevalence, as well as carries a high risk of several chronic diseases, including hypertension. Studies of the association between obesity and ambulatory bloodpressure (BP) are scarce and most use only body mass index (BMI) as indicator of adiposity.
A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in bloodpressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight. of their body weight.
This study aims to identify risk factors for new-onset HDP and to develop a prediction model for assessing the risk of new-onset hypertension during pregnancy.MethodsWe included 446 pregnant women without baseline hypertension from Liyang People's Hospital at the first inspection, and they were followed up until delivery.
The chi-squared test compared sociodemographic characteristics between HTN stages I and II.Results:Data from 1580 hypertensive participants with bloodpressure readings over 130/80 mmHg with or without anti-hypertensive treatment was analyzed. Median systolic and diastolic bloodpressure (BP) was 142.5
Background:In Central Asia, hypertension accounts for 14.5% Second group (n=24) consisted of pregnant women with chronic hypertension/CHT. A physical examination was performed, heart rate was assessed, bloodpressure was measured according to Korotkov method, body mass index (BMI) was calculated. P < 0.05
It increases the likelihood of developing chronic conditions such as heart disease, diabetes, and high bloodpressure. Food and Drug Administration (FDA) in 2021 as a once-weekly injection for chronic weight management in adults with obesity and at least one weight-related condition such as type 2 diabetes or hypertension.
Finally, the reproducibility of the results of cluster analysis is tested in an external cohort (validation set). Aims Patients experiencing ischaemic heart failure with reduced ejection fraction (HFrEF) represent a diverse group.
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] These individuals tend to have a better prognosis when compared to both individuals with normal weight (BMI of 18.5
Effects of resistance training on traditional CVD risk factors Bloodpressure Resistance exercise training has been shown to improve resting bloodpressure in cohorts of healthy adults and adults with varying levels of high bloodpressure.
Effects of resistance training on traditional CVD risk factors Bloodpressure Resistance exercise training has been shown to improve resting bloodpressure in cohorts of healthy adults and adults with varying levels of high bloodpressure.
Getty Images milla1cf Mon, 04/01/2024 - 08:10 April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high bloodpressure over time, according to a study presented at the American College of Cardiology ’s Annual Scientific Session. to 18 years). The age of the participants ranged from 35.4
Semaglutide-mediated improvements in HF-related symptoms and physical limitations were consistent in both male and female participants across key subgroups including age and BMI. It also lowered their systolic bloodpressure and waist circumference. vs -7.2%.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content